Johnson & Johnson
XBER:JNJ
Johnson & Johnson
XBER:JNJ
Price:
175.76
EUR
Market Closed
Market Cap:
€423.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
Johnson & Johnson
XBER:JNJ
|
US |
|
W
|
Welcron Hantec Co Ltd
KOSDAQ:076080
|
KR |
|
S
|
Shantou Dongfeng Printing Co Ltd
SSE:601515
|
CN |
|
K
|
K Cash Corp Ltd
HKEX:2483
|
HK |
|
BRP Inc
TSX:DOO
|
CA |
|
P
|
Petrolimex Petrochemical Corp JSC
VN:PLC
|
VN |
|
V
|
Vegetable Products Ltd
BSE:539132
|
IN |
|
Soditech SA
PAR:SEC
|
FR |
|
Cherry AG
XETRA:C3RY
|
DE |
|
T
|
T7 Global Bhd
KLSE:T7GLOBAL
|
MY |
|
Zoy Home Furnishing Co Ltd
SSE:603709
|
CN |
|
I-nexus Global PLC
LSE:INX
|
UK |
|
V
|
Vicostone JSC
VN:VCS
|
VN |
|
P
|
Polyplex Thailand PCL
SET:PTL
|
TH |
|
E
|
Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret AS
IST:EUPWR.E
|
TR |
|
Is Yatirim Menkul Degerler AS
IST:ISMEN.E
|
TR |
|
Jeudan A/S
CSE:JDAN
|
DK |
|
Datang Group Holdings Ltd
HKEX:2117
|
CN |
|
P
|
Panda Eco System Bhd
KLSE:PANDA
|
MY |
|
S
|
Shaanxi Lighte Optoelectronics Material Co Ltd
SSE:688150
|
CN |
|
Birla Tyres Ltd
NSE:BIRLATYRE
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
JNJ
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 175.76 EUR,
Johnson & Johnson
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JNJ Multiples-Based Value
LOCKED
Multiples Across Competitors
JNJ Competitors Multiples
Johnson & Johnson Competitors
Johnson & Johnson Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Johnson & Johnson
XBER:JNJ
|
576.1B EUR | 6.1 | 21.5 | 14.9 | 18.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.5B EUR | 2.1 | 12.6 | 10.5 | 10.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
